Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Maxwell

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Signal Transduction and Targeted Therapy|April 20, 2021
SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axisIshant Khurana, Scott Maxwell, Simon Royce, et al.
European Heart Journal Open|October 24, 2025
Ischaemic preconditioning regulates cardiac transcriptome via DNA methylation conferring cardio-protection from ischaemic reperfusion injuryAbdul Waheed Khan, Shafaat Hussain, Ahmed Elmahdy, et al.
Signal Transduction and Targeted Therapy|December 31, 2023
EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donorsKeith Al-Hasani, Safiya Naina Marikar, Harikrishnan Kaipananickal, et al.
Scientific Reports|January 26, 2021
Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathwaysMarina Barreto Felisbino, Mark Ziemann, Ishant Khurana, et al.
Cardiovascular Diabetology|January 29, 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational studyAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Thorax|March 1, 2012
Systemic elastin degradation in chronic obstructive pulmonary diseaseJohn D Maclay, David A McAllister, Roberto Rabinovich, et al.
Science Advances|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approachMisbah Aziz, Karly C Sourris, Jairo A Pinzon-Cortes, et al.
Diabetes Research and Clinical Practice|September 25, 2023
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitusIshant Khurana, Natasha J Howard, Scott Maxwell, et al.
Diabetes|June 21, 2024
The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA SequencingAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Journal of the American Society of Nephrology : JASN|April 17, 2024
Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial CellsScott Maxwell, Jun Okabe, Harikrishnan Kaipananickal, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Signal Transduction and Targeted Therapy|April 20, 2021
SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axisIshant Khurana, Scott Maxwell, Simon Royce, et al.
European Heart Journal Open|October 24, 2025
Ischaemic preconditioning regulates cardiac transcriptome via DNA methylation conferring cardio-protection from ischaemic reperfusion injuryAbdul Waheed Khan, Shafaat Hussain, Ahmed Elmahdy, et al.
Signal Transduction and Targeted Therapy|December 31, 2023
EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donorsKeith Al-Hasani, Safiya Naina Marikar, Harikrishnan Kaipananickal, et al.
Scientific Reports|January 26, 2021
Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathwaysMarina Barreto Felisbino, Mark Ziemann, Ishant Khurana, et al.
Cardiovascular Diabetology|January 29, 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational studyAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Thorax|March 1, 2012
Systemic elastin degradation in chronic obstructive pulmonary diseaseJohn D Maclay, David A McAllister, Roberto Rabinovich, et al.
Science Advances|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approachMisbah Aziz, Karly C Sourris, Jairo A Pinzon-Cortes, et al.
Diabetes Research and Clinical Practice|September 25, 2023
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitusIshant Khurana, Natasha J Howard, Scott Maxwell, et al.
Diabetes|June 21, 2024
The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA SequencingAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Journal of the American Society of Nephrology : JASN|April 17, 2024
Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial CellsScott Maxwell, Jun Okabe, Harikrishnan Kaipananickal, et al.
Pageof 4